Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Clinical trial NCT02555189 · TERMINATED

Trial details

NCT number: NCT02555189
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone Stage IV Prostate Cancer AJCC v7

Start date: 2015-12-01
Primary completion: 2022-12-07
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.